Recently, Zhang et al. demonstrated that cancer-associated mutations of SF3B1 mainly disrupt SF3B1 interaction with SUGP1 during BP recognition and that the loss of this interaction solely accounts for the splicing errors caused by SF3B1 mutations [22]. This evidence concerns the gene SUGP1 and cancer.